SLC7A11 and hepatocellular carcinoma: To investigate the therapeutic effect of ferroptosis in HCC, we selected sulfasalazine, an inhibitor of SLC7A11/system xc−, as a ferroptosis‐inducing drug in our study and designed chitosan hydrochloride and oxidized dextran hydrogel to improve drug delivery and maintain effective drug concentration in the peritoneal cavity.